Publications by authors named "Kenneth Arthur"

Claim this Profile
I
Immune activation by DNA damage predicts response to chemotherapy and survival in oesophageal adenocarcinoma.
Richard C Turkington, Laura A Knight, Jaine K Blayney, Maria Secrier, Rosalie Douglas, Kenneth Arthur

Gut· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glucose transporter 1 expression as a marker of prognosis in oesophageal adenocarcinoma.
Jaine K Blayney, Lauren Cairns, Gerald Li, Niamh McCabe, Leanne Stevenson, Kenneth Arthur

Oncotarget· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Statin use, candidate mevalonate pathway biomarkers, and colon cancer survival in a population-based cohort study.
Ronan T Gray, Maurice B Loughrey, Peter Bankhead, Chris R Cardwell, Stephen McQuaid, Kenneth Arthur

Br J Cancer· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of PTGS2 Expression, PIK3CA Mutation, Aspirin Use and Colon Cancer Survival in a Population-Based Cohort Study.
Ronan T Gray, Marie M Cantwell, Helen G Coleman, Maurice B Loughrey, Peter Bankhead, Kenneth Arthur

Clin Transl Gastroenterol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Whole slide image cytometry: a novel method to detect abnormal DNA content in Barrett's esophagus.
Yinhai Wang, Damian T McManus, Kenneth Arthur, Brian T Johnston, Andrew J Kennedy

Lab Invest· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RALA-mediated delivery of FKBPL nucleic acid therapeutics.
Rachel Bennett, Anita Yakkundi, Hayley D McKeen, Lana McClements, Thomas J McKeogh, Kenneth Arthur

Nanomedicine (Lond)· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FKBPL is a critical antiangiogenic regulator of developmental and pathological angiogenesis.
Anita Yakkundi, Rachel Bennett, Ivette Hernández-Negrete, Jean-Marie Delalande, Mary Hanna, Kenneth Arthur

Arterioscler Thromb Vasc Biol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of wntless (WLS) expression in gastric, ovarian, and breast cancers reveals a strong association with HER2 overexpression.
Jonathan Stewart, Jacqueline James, Glenn W McCluggage, Stephen McQuaid, Kenneth Arthur

Mod Pathol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BAK and NOXA are critical determinants of mitochondrial apoptosis induced by bortezomib in mesothelioma.
Sara Busacca, Alex D Chacko, Astero Klabatsa, Kenneth Arthur, Michael Sheaff

PLoS One· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PTEN phosphatase-independent maintenance of glandular morphology in a predictive colorectal cancer model system.
Ishaan C Jagan, Ravi K Deevi, Aliya Fatehullah, Rebecca Topley, Joshua Eves, Kenneth Arthur

Neoplasia· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The deubiquitinating enzyme USP17 is associated with non-small cell lung cancer (NSCLC) recurrence and metastasis.
Cheryl McFarlane, Suzanne McFarlane, Ian Paul, Kenneth Arthur, Michael Scheaff

Oncotarget· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population-based study reveals new risk-stratification biomarker panel for Barrett's esophagus.
Elizabeth L Bird-Lieberman, Jason M Dunn, Helen G Coleman, Pierre Lao-Sirieix, Dahmane Oukrif, Kenneth Arthur

Gastroenterology· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRCA1 is an essential mediator of vinorelbine-induced apoptosis in mesothelioma.
Sara Busacca, Michael Sheaff, Kenneth Arthur, Steven G Gray, Kenneth J O'Byrne

J Pathol· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PARP inhibition induces BAX/BAK-independent synthetic lethality of BRCA1-deficient non-small cell lung cancer.
Ian Paul, Kienan I Savage, Jaine K Blayney, Elisabeth Lamers, Kathy Gately, Kenneth Arthur

J Pathol· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis